USTEKINUMAB

ustekinumab 130 mg/26 mL injection, 26 mL vial

USTEKINUMAB (13804M)

ustekinumab 130 mg/26 mL injection, 26 mL vial
13804M
Body System:
Manner of administration:Injection
Private
S100 HSD Private
Authority Required

Restriction

Indication: Complex refractory Fistulising Crohn disease
Treatment phase: Initial treatment - Initial 1 (new patient or recommencement of treatment after a break in biological medicine of more than 5 years)

Restriction

Indication: Complex refractory Fistulising Crohn disease
Treatment phase: Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)

Restriction

Indication: Complex refractory Fistulising Crohn disease
Treatment phase: Initial 1 (new patient or recommencement of treatment after a break in biological medicine of more than 5 years), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) - balance of supply
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 4 Max qty units: 4 # of repeats: 0 DPMQ: $2,291.80 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Stelara
Steqeyma